Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05846802 · ClinicalTrials.gov registry record

Gastroparesis Registry 4

A clinical trial of Gastroparesis and Gastro-Intestinal Disorder, sponsored by Johns Hopkins Bloomberg School of Public Health.

Recruiting
Registry status
250
Enrollment target
6
Study locations

NCT05846802: Recruiting study of Gastroparesis and Gastro-Intestinal Disorder, sponsored by Johns Hopkins Bloomberg School of Public Health.

NCT05846802 is a study of Gastroparesis and Gastro-Intestinal Disorder that is actively recruiting participants, run by Johns Hopkins Bloomberg School of Public Health. The registered enrollment target is 250 participants, below the 296-participant average among 44 other Gastroparesis trials with a reported enrollment target (16% lower). The trial reports 6 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05846802, a study of Gastroparesis and Gastro-Intestinal Disorder, is actively recruiting participants, sponsored by Johns Hopkins Bloomberg School of Public Health.

RECRUITING
Registry status
250 participants
Enrollment target
6
Study locations

Study Summary

The Gastroparesis Registry 4 (GpR4) is an observational study of patients with symptoms of gastroparesis (Gp) and functional dyspepsia (FD) with either delayed or normal gastric emptying. To better understand these disorders, this registry will capture demographic, clinical, physiological, questionnaire, and patient outcome data to characterize the patients and their clinical course. Participants will complete several questionnaires, complete a nutrient drink test and have a gastric emptying study.

Primary Outcome

Change in PAGI-SYM total score from baseline to 48 weeks. The final PAGI-SYM contains 20 items grouped into 6 subscales covering: heartburn/regurgitation (7 items), nausea/vomiting (3 items), post-prandial fullness/early satiety (4 items), bloating (2 items), upper abdominal pain (2 items), and lower abdominal pain (2 items). A 6-point Likert response scale, ranging from 0 (none) to 5 (very severe), is used for rating the severity of each symptom item over a 2-week recall period. * Subscale sc

Conditions Studied

Gastroparesis Gastro-Intestinal Disorder Gastroparesis Nondiabetic Gastroparesis Due to Diabetes Mellitus Type I Gastroparesis Due to Diabetes Mellitus Type II Functional Disorder of Gastrointestinal Tract

Study Locations (6)

Arizona

  • Jay Pasricha - Scottsdale

Kentucky

  • University of Louisville - Louisville

Massachusetts

  • Massachusetts General Hospital - Boston

North Carolina

  • Wake Forest University and Atrium Health Carolinas Medical Center - Charlotte

Pennsylvania

  • Temple University Hospital - Philadelphia

Texas

  • Texas Tech University Health Science Center (TTUHSC) - El Paso

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2024-09-20
Est. Completion 2027-04-30
Johns Hopkins Bloomberg School of Public Health

187 total trials

What NCT05846802 shows while recruiting

NCT05846802 is an observational study that tracks outcomes without assigning an intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, below the 296-participant average among 44 other Gastroparesis trials with a reported enrollment target (16% lower).

The record links to 6 conditions, with Gastroparesis appearing as the primary indexed condition, and to 0 interventions.

NCT05846802 lists 6 locations in 6 states (Arizona, Kentucky, Massachusetts).

Frequently Asked Questions

What is clinical trial NCT05846802 about?

NCT05846802 is a clinical study titled "Gastroparesis Registry 4". The Gastroparesis Registry 4 (GpR4) is an observational study of patients with symptoms of gastroparesis (Gp) and functional dyspepsia (FD) with either delayed or normal gastric emptying. To better understand these disorders, this registry will capture demographic, clinical, physiological, questionn...

What is the current status of trial NCT05846802?

This trial is currently recruiting. The enrollment target is 250 participants. The study started on 2024-09-20. Estimated completion is 2027-04-30.

What conditions does trial NCT05846802 study?

This clinical trial studies the following conditions: Gastroparesis, Gastro-Intestinal Disorder, Gastroparesis Nondiabetic, Gastroparesis Due to Diabetes Mellitus Type I, Gastroparesis Due to Diabetes Mellitus Type II.

Who is sponsoring clinical trial NCT05846802?

This trial is sponsored by Johns Hopkins Bloomberg School of Public Health, which has 187 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05846802 being conducted?

This trial has 6 study locations across Arizona, Kentucky, Massachusetts, North Carolina, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Gastroparesis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05846802's enrollment target sits among peer trials

250 9th of 44 higher than 35 of 44 other Gastroparesis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Gastroparesis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00483249 · 250 participants · NA

    Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm

  • NCT00777712 · 250 participants

    Mechanisms Underlying Impaired Diabetic Wound Healing

  • NCT01451502 · 250 participants · NA

    Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units

  • NCT01771718 · 250 participants

    Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT05846802

Source: ClinicalTrials.gov NCT05846802, the US trial registry maintained by the National Library of Medicine. NCT05846802 (mid enrollment · multi site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.